维普中文期刊产品整合服务
56篇 您的检索式:作者名="Francisco AL"
    题名 作者 年代 出处 被引量
1Characterization of hepatitis B virus X gene quasispecies complexity in mono-infection and hepatitis delta virus superinfection显示文摘Hepatitis delta virus(HDV) seems to strongly suppress hepatitis B virus(HBV)replication, although little is known about the mechanism of this interaction. Both these viruses show a dynamic distribution of mutants, resulting in viral quasispecies. Next-generation sequencing is a viable approach for analyzing the composition of these mutant spectra. As the regulatory hepatitis B X protein(HBx) is essential for HBV replication, determination of HBV X gene(HBX)quasispecies complexity in HBV/HDV infection compared to HBV monoinfection may provide information on the interactions between these two viruses.AIM To compare HBV quasispecies complexity in the HBX 5' region between chronic hepatitis delta(CHD) and chronic HBV mono-infected patients.METHODS Twenty-four untreated patients were included: 7/24(29.2%) with HBeAgnegative chronic HBV infection(CI, previously termed inactive carriers), 8/24(33.3%) with HBeAg-negative chronic hepatitis B(CHB) and 9/24(37.5%) with CHD. A serum sample from each patient was first tested for HBV DNA levels.The HBX 5' region [nucleotides(nt) 1255-1611] was then PCR-amplified for subsequent next-generation sequencing(MiSeq, Illumina, United States). HBV quasispecies complexity in the region analyzed was evaluated using incidencebased indices(number of haplotypes and number of mutations), abundancebased indices(Hill numbers of order 1 and 2), and functional indices(mutation frequency and nucleotide diversity). We also evaluated the pattern of nucleotide changes to investigate which of them could be the cause of the quasispecies complexity.RESULTS CHB patients showed higher median HBV-DNA levels [5.4 logIU/mL,interquartile range(IQR) 3.5-7.9] than CHD(3.4 logIU/mL, IQR 3-7.6)(P = n.s.)or CI(3.2 logIU/mL, IQR 2.3-3.5)(P < 0.01) patients. The incidence and abundance indices indicated that HBV quasispecies complexity was significantly greater in CI than CHB. A similar trend was observed in CHD patients, although only Hill numbers of order 2 showed statistically significant differences(CHB2.81, IQR 1.11-4.57 vs CHD 8.87, 6.56-11.18, P = 0.038). There were no significant differences in the functional indices, but CI and CHD patients also showed a trend towards greater complexity than CHB. No differences were found for any HBV quasispecies complexity indices between CHD and CI patients. G-to-A and C-to-T nucleotide changes, characteristic of APOBEC3 G, were higher in CHD and CI than in CHB in genotype A haplotypes, but not in genotype D. The proportion of nt G-to-A vs A-to-G changes and C-to-T vs T-to-C changes in genotype A and D haplotypes in CHD patients showed no significant differences. In CHB and CI the results of these comparisons were dependent on HBV genotype.CONCLUSION The lower-replication CHD and CI groups show a trend to higher quasispecies complexity than the higher-replication CHB group. The mechanisms associated with this greater complexity require elucidation.Cristina Godoy David Tabernero Sara Sopena Josep Gregori Maria Francesca Cortese Carolina González Rosario Casillas Mar?al Yll Ariadna Rando Rosa López-Martínez Josep Quer Gloria González-Aseguinolaza Rafael Esteban Mar Riveiro-Barciela Maria Buti Francisco Rodríguez-Frías 2019World Journal of Gastroenterology2019,25,13:6
2Beneficial effects of nutritional supplements on intestinal epithelial barrier functions in experimental colitis models in vivo显示文摘Acute and chronic colitis affect a huge proportion of the population world-wide.The etiology of colitis cases can be manifold,and diet can significantly affect onset and outcome of colitis.While many forms of acute colitis are easily treatable,chronic forms of colitis such as ulcerative colitis and Crohn’s disease(summarized as inflammatory bowel diseases)are multifactorial with poorly understood pathogenesis.Inflammatory bowel diseases are characterized by exacerbated immune responses causing epithelial dysfunction and bacterial translocation.There is no cure and therapies aim at reducing inflammation and restoring intestinal barrier function.Unfortunately,most drugs can have severe side effects.Changes in diet and inclusion of nutritional supplements have been extensively studied in cell culture and animal models,and some supplements have shown promising results in clinical studies.Most of these nutritional supplements including vitamins,fatty acids and phytochemicals reduce oxidative stress and inflammation and have shown beneficial effects during experimental colitis in rodents induced by dextran sulphate sodium or 2,4,6-trinitrobenzene sulfonic acid,which remain the gold standard in pre-clinical colitis research.Here,we summarize the mechanisms through which such nutritional supplements contribute to epithelial barrier stabilization.Hilda Vargas-Robles Karla Fabiola Castro-Ochoa Alí Francisco Citalán-Madrid Michael Schnoor 2019World Journal of Gastroenterology2019,25,30:5
3Magnesium-its role in CKD显示文摘M de Francisco AL Rodriguez M 2013Nefrolagia2013,33,3:1
4Parathyroidectomy in dialysis patients显示文摘De Francisco AL Fresnedo GF Rodrigo E 2002Kidney Int Suppl2002,,80:1
5Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency显示文摘MACDOUGALL IC CANAUD B de FRANCISCO AL et 02 2012Eur J Heart Fail2012,14,8:1
6Past,present and future of erythropoietin use in the elderly显示文摘de Francisco AL Fernandez FG Rodrigo E 2002Iht Urol Nephrol2002,33,:1
7Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis 显示文摘Block GA Martin KJ de Francisco AL 2004N Engl J Med2004,35,:1
8Calcium-mediated parathyroid honnone release changes in patients treated with the calcimimetic agent cinacalcet显示文摘de Francisco AL Izquierdo M Cunningham J 2008Nephrol Dial Transplant2008,23,9:1
9Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway显示文摘Mariano Janiszewski Alípio O. do Carmo Marcelo A. Pedro Eliézer Silva Elias Knobel Francisco R. M. Laurindo 2004Critical Care Medicine2004,,3:1
10Develop- ment and Testing of A Prototype of Low - Power Water -Ammonia Absorption Equipment for Solar Energy Applications 显示文摘De Francisco A Illanes R Torres J L et al 2002Renewable Energy2002,25,:1
11Serum interleukin-6 in renal osteodystrophy:relationship with serum PTH and bone remodeling markers显示文摘Montalban C Garcia-Unzueta MT De Francisco AL 1999Horm Metab Res1999,31,1:1
12Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis显示文摘Block GA Martin KJ de Francisco AL 2004N Engl J Med2004,350,:1
13Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemo- dialysis patients: a controlled randomized study (CALM- AG study) assessing efficacy and tolerability显示文摘Francisco AL Leidig M Covie AC 2010Nephrol Dial Transplant2010,25,:1
14Role of commercial sanitizers and washing systems on epiphytic microorganisms and sensory quality of fresh-cut escarole and lettuce显示文摘Allende A Selma MV Francisco LG e t al 2008Postharvest Biology and Technology2008,49,1:1
15Application Danielsson B, of supercritical Kozubek A, et carbon dioxide for the extraction of alkylresorcinols from rye bran 显示文摘Francisco J C al 2005Supercritical Fluids2005,35,3:1
16Calcimimetic for secondary hyperparathyroidism in patients receiving hemodialysis 显示文摘Block GA Martin KJ de Francisco AL 2004N Engl J Med2004,350,:1
17Double treatment with paricalcitol-associated calcifediol and cardiovascular risk biomarkers in haemodialysis 显示文摘Pifiera-Haces C Izquierdo-Ortiz MJ Martin-de Francisco AL 2013Nefrologia2013,33,1:1
18Diabetic mastopathy: a case report显示文摘Francisco C Julio C Fontes AL 2012Clin Imaging2012,36,6:1
19High-Efficiency Postdilution Online Hemodiafiltra- tion Reduces All-Cause Mortality in Hemodialysis Pa tients显示文摘Francisco Maduell Francesc Moreso Mercedes Pons et al 2013J Am Soc Nephrol2013,24,:1
20Association between pulse pressure and cardiovascular disease in renal transplant patients显示文摘Fernandez-Fresnedo G Escallada R Martin de Francisco AL 2005Am J Transplant2005,5,2:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费